Authors/Disclosures
|
Eliza M. Gordon-Lipkin, MD
(Kennedy Krieger Institute)
|
No disclosure on file |
|
Schiffon Wong
|
Schiffon Wong has received personal compensation for serving as an employee of EMD Serono. |
|
Douglas G. Postels, MD
(Michigan State University, Neurology)
|
No disclosure on file |
|
Doungporn Ruthirago, MD
(Bangkok International Hospital)
|
No disclosure on file |
|
Anusha Yeshokumar, MD
(Icahn School of Medicine at Mount Sinai)
|
Dr. Yeshokumar has nothing to disclose. |
|
Ana Arenivas, PhD
(Kennedy Krieger Institute)
|
No disclosure on file |
|
|
No disclosure on file |
|
Deanna Saylor, MD, MHS, FÂé¶¹´«Ã½Ó³»
(Johns Hopkins Hospital)
|
Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Âé¶¹´«Ã½Ó³». The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from Âé¶¹´«Ã½Ó³». Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Âé¶¹´«Ã½Ó³»al Innovation Commitees with American Neurological Association that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |
|
|
No disclosure on file |
|
John Probasco, MD, FÂé¶¹´«Ã½Ó³»
(The Johns Hopkins Hospital)
|
Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech. |